Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s share price hit a new 52-week low on Monday . The company traded as low as GBX 30 ($0.39) and last traded at GBX 30.06 ($0.39), with a volume of 20110 shares changing hands. The stock had previously closed at GBX 33 ($0.43).
Cambridge Cognition Stock Down 8.9 %
The stock has a market cap of £12.61 million, a price-to-earnings ratio of -751.38 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53. The stock has a fifty day moving average of GBX 40.72 and a two-hundred day moving average of GBX 43.91.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Articles
- Five stocks we like better than Cambridge Cognition
- What is the Nikkei 225 index?
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- How to Most Effectively Use the MarketBeat Earnings Screener
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- Health Care Stocks Explained: Why You Might Want to Invest
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
